Using genome-wide complex trait analysis to quantify 'missing heritability' in Parkinson's disease.

Genome-wide association studies (GWASs) have been successful at identifying single-nucleotide polymorphisms (SNPs) highly associated with common traits; however, a great deal of the heritable variation associated with common traits remains unaccounted for within the genome. Genome-wide complex trait...

Full description

Bibliographic Details
Main Authors: Keller, M, Saad, M, Bras, J, Bettella, F, Nicolaou, N, Simón-Sánchez, J, Mittag, F, Büchel, F, Sharma, M, Gibbs, JR, Schulte, C, Moskvina, V, Durr, A, Holmans, P, Kilarski, L, Guerreiro, R, Hernandez, D, Brice, A, Ylikotila, P, Stefánsson, H, Majamaa, K, Morris, H, Williams, N, Gasser, T, Heutink, P
Format: Journal article
Language:English
Published: 2012
Description
Summary:Genome-wide association studies (GWASs) have been successful at identifying single-nucleotide polymorphisms (SNPs) highly associated with common traits; however, a great deal of the heritable variation associated with common traits remains unaccounted for within the genome. Genome-wide complex trait analysis (GCTA) is a statistical method that applies a linear mixed model to estimate phenotypic variance of complex traits explained by genome-wide SNPs, including those not associated with the trait in a GWAS. We applied GCTA to 8 cohorts containing 7096 case and 19 455 control individuals of European ancestry in order to examine the missing heritability present in Parkinson's disease (PD). We meta-analyzed our initial results to produce robust heritability estimates for PD types across cohorts. Our results identify 27% (95% CI 17-38, P = 8.08E - 08) phenotypic variance associated with all types of PD, 15% (95% CI -0.2 to 33, P = 0.09) phenotypic variance associated with early-onset PD and 31% (95% CI 17-44, P = 1.34E - 05) phenotypic variance associated with late-onset PD. This is a substantial increase from the genetic variance identified by top GWAS hits alone (between 3 and 5%) and indicates there are substantially more risk loci to be identified. Our results suggest that although GWASs are a useful tool in identifying the most common variants associated with complex disease, a great deal of common variants of small effect remain to be discovered.